InnoMed PredTox

InnoMed PredTox

Research-Project
name=InnoMed PredTox
title=Innovative Medicines for Europe - Predictive Toxicology
keywords=Toxicogenomics, Drug development, Pre-clinical development
fundingAgency=European Commission
frameworkProgramme=FP6


projectType=Integrated Project
researchObjective=Assess the value of combining results from omics technologies together with the results from more conventional toxicology methods for more informed decision making in preclinical safety evaluation
projectReference=FP6-518170
coordinator=EFPIA
participants=EFPIA Companies
Bayer Schering Pharma
Boehringer-Ingelheim
Johnson and Johnson
Lilly
Merck Serono
Novartis
Novo Nordisk
Nycomed
Roche
Sanofi-Aventis
Schering-Plough
Servier Universities
University of Würzburg
University College Dublin
Hacettepe University Technology Providers
Bio-Rad
Genedata|budget=8 Mio. EUR
funding=
start=1 October 2005
end=31 January 2009
website=http://www.innomed-predtox.com

InnoMed PredTox is a joint Industry and European Commission collaboration to improve drug safety. The consortium is composed of 15 research groups from 12 pharmaceutical companies, three academic institutions and two technology providers.The goal of InnoMed PredTox is to assess the value of combining results from omics technologies together with the results from more conventional toxicology methods for more informed decision making in preclinical safety evaluation.

The project was initiated in October 2005 with a term of 40 month. It receives funding as an Integrated Project under the Sixth Framework Programme. The project had been set up jointly by the European Federation of Pharmaceutical Industries and Associations (EFPIA) and the European Commission as a pilot project for the subsequent design of the Innovative Medicines Initiative [IMI website by EFPIA [http://www.imi-europe.org/pilot%20project/pages/default.aspx] ] [European Commission website [http://imi.europa.eu/innomed_en.html] ]

As part of the project the partners ran a series of regular 14 days toxicological studies with daily dosing. The compounds had been selected representing compounds with promising drug-like properties but that had been terminated due to toxic effects on the liver and/or kidneys of rats).

The project collected and jointly analysed transcriptomics, proteomics, metabonomics and conventional toxicological data on 14 failed drug candidates together with two reference compounds [Mulrane et al., Exp Toxicol Pathol. 2008 Aug;60(4-5):235-45 [http://www.ncbi.nlm.nih.gov/pubmed/18479893] ] , troglitazone [E. Troesken et al., Application of a Systems Toxicology Approach to Investigate Troglitazone Hepatotoxicity in the Rat, Abstract ID 675, The Toxicologist CD — An official Journal of the Society of Toxicology, Volume 102, Number S-1, March 2008 [http://www.toxicology.org/ai/pub/publications.asp] [http://www.innomed-predtox.com/media__events/publications/index_eng.html (slides)] ] and gentamicin [E. Com et al., Integrated Transcriptomic and Proteomic Evaluation of Gentamicin Nephrotoxicity in Rats, Abstract ID 676, The Toxicologist CD — An official Journal of the Society of Toxicology, Volume 102, Number S-1, March 2008 [http://www.toxicology.org/ai/pub/publications.asp] [http://www.innomed-predtox.com/media__events/publications/index_eng.html (slides)] ] . As data integration across different data areas and technology platforms is considered a prerequisite to building a consistent standardised data schema for joint analysis [A.M. Richard, Chem Res Toxicol. 2006 Oct;19(10):1257-62 [http://www.ncbi.nlm.nih.gov/pubmed/17040094] ] all project data are stored in a database [W.B. Mattes, Methods Mol Biol. 2008;460:221-38. [http://www.ncbi.nlm.nih.gov/pubmed/18449490] ] custom developed by Genedata.

Milestones

Status: August 2008

References

See also

* EFPIA
* Toxicogenomics
* Innovative Medicines Initiative

External links

* [http://www.innomed-predtox.com/ InnoMed PredTox] official project website
* [http://www.imi-europe.org/ Innovative Medicines Initiative] - EFPIA website
* [http://imi.europa.eu Innovative Medicines Initiative] - European Commission website
* [http://www.innomed-predtox.com/links/index_eng.html List of Related Projects]


Wikimedia Foundation. 2010.

Игры ⚽ Нужен реферат?

Look at other dictionaries:

  • European Federation of Pharmaceutical Industries and Associations — The European Federation of Pharmaceutical Industries and Associations or EFPIA is the organization representing the research based pharmaceutical industry operating in Europe. The EFPIA was created in 1978. [… …   Wikipedia

  • Toxicogenomics — is a field of science that deals with the collection, interpretation, and storage of information about gene and protein activity within particular cell or tissue of an organism in response to toxic substances. Toxicogenomics meshes toxicology… …   Wikipedia

  • Novartis — Sandoz Laboratories redirects here. For the new Sandoz company founded in 2003, see Sandoz. Novartis International AG Type Public AG Traded as SIX:  …   Wikipedia

  • Schering-Plough — Corporation Type Subsidiary Industry Pharmaceuticals Fate Merged with Merck Co …   Wikipedia

  • Hoffmann–La Roche — Infobox Company company name = F. Hoffmann–La Roche, Ltd. company company type = Public (parent company Roche Holding AG traded under RHHBY.PK) foundation = 1896 location=flagicon|CH|size=30x15px Basel, Switzerland, Roche US in Nutley, NJ key… …   Wikipedia

  • Sanofi-Aventis — Infobox Company company name = Sanofi Aventis company company type = Public (Euronext [http://www.euronext.com/trader/summarizedmarket/0,5372,1732 6834,00.html?selectedMep=1 idInstrument=20812 isinCode=FR0000120578 SAN] , NYSE, LSE and FWB)… …   Wikipedia

  • Eli Lilly and Company — Infobox Company company name = Eli Lilly and Company company company type = Public (NYSE: [http://www.nyse.com/about/listed/lcddata.html?ticker=LLY LLY] ) foundation = 1876 company slogan = Answers that matter location = Indianapolis, Indiana,… …   Wikipedia

  • Novo Nordisk — A/S Type Publicly traded Aktieselskab (OMX: NOVO B, NYSE:  …   Wikipedia

  • Sixth Framework Programme — The Sixth Framework Programme (abbreviated FP6) was the Framework Programme for Research and Technological Development from 2002 till 2006 set up by the European Union (EU) in order to fund and promote European research and technological… …   Wikipedia

  • Nycomed — International Management GmbH Type Private Industry Pharmaceuticals Founded 1874 Headquarters …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”